Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.
Identifieur interne : 000B03 ( Main/Corpus ); précédent : 000B02; suivant : 000B04Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.
Auteurs : Souraya Domiati ; Mohamad Itani ; Ghida ItaniSource :
- Frontiers in medicine [ 2296-858X ] ; 2020.
Abstract
Objectives: Distinct measures were adopted in Lebanon to prohibit the spreading of SARS-CoV-2. These actions provide positive results only if the population chooses to be compliant. Aim: Accordingly, this study aimed to reflect the Lebanese population adherence by determining their level of knowledge and practice during this pandemic. Method: A cross-sectional online survey was performed in April 2020. It involved 410 volunteers from the main 5 Lebanese districts. The questionnaire was divided into 3 parts; sociodemographic, knowledge, and practice. A score was calculated out of 18 points to evaluate the knowledge of the respondents. The last 8 questions reflected the participants' precautionary methods during the pandemic. Descriptive statistics and one-way analysis of variance tests were conducted using SPSS version 20. Results: The overall correct rate of the knowledge questionnaire was 75%. Survey completers of extreme age groups (under 18 and >44), elementary education level, and medical occupation displayed the least level of knowledge compared to other groups (p < 0.05). Most of the participants showed proactive practices to protect themselves against COVID-19. They covered their mouths (81.2%), threw the used tissues (93.7%), and washed their hands (66.6%) after sneezing or coughing. Moreover, they wore face masks if they were sick (59%) or in a crowded place (79.3%). Concerning Hydroxychloroquine, 10% claimed that they would take it if they have COVID-19 symptoms. Conclusion: This survey sheds the light on the fact that one mandatory measure does not fit all the population; there must be a specialized method of prevention for each profession, age group, and area of the country to prevent the outbreak of COVID-19.
DOI: 10.3389/fmed.2020.00542
PubMed: 33015096
PubMed Central: PMC7461812
Links to Exploration step
pubmed:33015096Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.</title>
<author><name sortKey="Domiati, Souraya" sort="Domiati, Souraya" uniqKey="Domiati S" first="Souraya" last="Domiati">Souraya Domiati</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Itani, Mohamad" sort="Itani, Mohamad" uniqKey="Itani M" first="Mohamad" last="Itani">Mohamad Itani</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Itani, Ghida" sort="Itani, Ghida" uniqKey="Itani G" first="Ghida" last="Itani">Ghida Itani</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33015096</idno>
<idno type="pmid">33015096</idno>
<idno type="doi">10.3389/fmed.2020.00542</idno>
<idno type="pmc">PMC7461812</idno>
<idno type="wicri:Area/Main/Corpus">000B03</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B03</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.</title>
<author><name sortKey="Domiati, Souraya" sort="Domiati, Souraya" uniqKey="Domiati S" first="Souraya" last="Domiati">Souraya Domiati</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Itani, Mohamad" sort="Itani, Mohamad" uniqKey="Itani M" first="Mohamad" last="Itani">Mohamad Itani</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Itani, Ghida" sort="Itani, Ghida" uniqKey="Itani G" first="Ghida" last="Itani">Ghida Itani</name>
<affiliation><nlm:affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Frontiers in medicine</title>
<idno type="ISSN">2296-858X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><b>Objectives:</b>
Distinct measures were adopted in Lebanon to prohibit the spreading of SARS-CoV-2. These actions provide positive results only if the population chooses to be compliant. <b>Aim:</b>
Accordingly, this study aimed to reflect the Lebanese population adherence by determining their level of knowledge and practice during this pandemic. <b>Method:</b>
A cross-sectional online survey was performed in April 2020. It involved 410 volunteers from the main 5 Lebanese districts. The questionnaire was divided into 3 parts; sociodemographic, knowledge, and practice. A score was calculated out of 18 points to evaluate the knowledge of the respondents. The last 8 questions reflected the participants' precautionary methods during the pandemic. Descriptive statistics and one-way analysis of variance tests were conducted using SPSS version 20. <b>Results:</b>
The overall correct rate of the knowledge questionnaire was 75%. Survey completers of extreme age groups (under 18 and >44), elementary education level, and medical occupation displayed the least level of knowledge compared to other groups (<i>p</i>
< 0.05). Most of the participants showed proactive practices to protect themselves against COVID-19. They covered their mouths (81.2%), threw the used tissues (93.7%), and washed their hands (66.6%) after sneezing or coughing. Moreover, they wore face masks if they were sick (59%) or in a crowded place (79.3%). Concerning Hydroxychloroquine, 10% claimed that they would take it if they have COVID-19 symptoms. <b>Conclusion:</b>
This survey sheds the light on the fact that one mandatory measure does not fit all the population; there must be a specialized method of prevention for each profession, age group, and area of the country to prevent the outbreak of COVID-19.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33015096</PMID>
<DateRevised><Year>2020</Year>
<Month>10</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>7</Volume>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in medicine</Title>
<ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation>
</Journal>
<ArticleTitle>Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>542</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2020.00542</ELocationID>
<Abstract><AbstractText><b>Objectives:</b>
Distinct measures were adopted in Lebanon to prohibit the spreading of SARS-CoV-2. These actions provide positive results only if the population chooses to be compliant. <b>Aim:</b>
Accordingly, this study aimed to reflect the Lebanese population adherence by determining their level of knowledge and practice during this pandemic. <b>Method:</b>
A cross-sectional online survey was performed in April 2020. It involved 410 volunteers from the main 5 Lebanese districts. The questionnaire was divided into 3 parts; sociodemographic, knowledge, and practice. A score was calculated out of 18 points to evaluate the knowledge of the respondents. The last 8 questions reflected the participants' precautionary methods during the pandemic. Descriptive statistics and one-way analysis of variance tests were conducted using SPSS version 20. <b>Results:</b>
The overall correct rate of the knowledge questionnaire was 75%. Survey completers of extreme age groups (under 18 and >44), elementary education level, and medical occupation displayed the least level of knowledge compared to other groups (<i>p</i>
< 0.05). Most of the participants showed proactive practices to protect themselves against COVID-19. They covered their mouths (81.2%), threw the used tissues (93.7%), and washed their hands (66.6%) after sneezing or coughing. Moreover, they wore face masks if they were sick (59%) or in a crowded place (79.3%). Concerning Hydroxychloroquine, 10% claimed that they would take it if they have COVID-19 symptoms. <b>Conclusion:</b>
This survey sheds the light on the fact that one mandatory measure does not fit all the population; there must be a specialized method of prevention for each profession, age group, and area of the country to prevent the outbreak of COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020 Domiati, Itani and Itani.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Domiati</LastName>
<ForeName>Souraya</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Itani</LastName>
<ForeName>Mohamad</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Itani</LastName>
<ForeName>Ghida</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Front Med (Lausanne)</MedlineTA>
<NlmUniqueID>101648047</NlmUniqueID>
<ISSNLinking>2296-858X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Lebanese</Keyword>
<Keyword MajorTopicYN="N">attitude</Keyword>
<Keyword MajorTopicYN="N">knowledge</Keyword>
<Keyword MajorTopicYN="N">pandemic</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>05</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>07</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>21</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>10</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33015096</ArticleId>
<ArticleId IdType="doi">10.3389/fmed.2020.00542</ArticleId>
<ArticleId IdType="pmc">PMC7461812</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nature. 2020 May;581(7808):247-248</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409766</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mil Med Res. 2020 Mar 13;7(1):11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32169119</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Apr 27;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32338708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hosp Infect. 2020 Jun;105(2):183-187</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32278701</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Community Health. 2020 Oct;45(5):881-890</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32318986</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hautarzt. 1991 Mar;42(3):140-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2055762</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Biol Sci. 2020 Mar 15;16(10):1686-1697</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32226286</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Jun;582(7813):469</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32546811</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Biol Sci. 2020 Mar 15;16(10):1745-1752</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32226294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JMIR Public Health Surveill. 2020 Apr 30;6(2):e19160</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32320381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Microbiol. 2017 Jan;25(1):35-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27743750</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Allergy. 2020 Jul;75(7):1742-1752</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32239761</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Rev Microbiol. 2020 Mar;46(2):182-193</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282268</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2020 May;94:119-124</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32247050</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Autoimmun. 2020 May;109:102433</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32113704</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Apr;580(7805):576-577</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32346146</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Asian J Psychiatr. 2020 Jun;51:102083</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32283510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2020 Jul;81(1):1-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32315723</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B03 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000B03 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:33015096 |texte= Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:33015096" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |